Article
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globally
2026-07-23
Abstract excerpt
<title>Abstract</title> <p> <bold>Introduction:</bold> Adaptive platform trials rapidly generate robust evidence, essential for resource-limited health systems like those in low- and middle-income countries (LMICs). We analyzed the return on investment of an adaptive platform trial using Value of Implementation analysis. <bold>Methods:</bold> This was a retrospective observational cohort study comparing the u...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 15e44d7e-097e-5f60-acdc-4086223b11ab
- DOI
- 10.21203/rs.3.rs-6264788/v3
